byiShook Opinion
Sep 16, 2024 - 14:35
Biotech stocks Nuvalent and Iteos diverged Monday on updates for their lung cancer treatments at the ESMO meeting in Madrid. The post Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths appeared first on Investor's Business Daily.
Biotech stocks Nuvalent and Iteos diverged Monday on updates for their lung cancer treatments at the ESMO meeting in Madrid.
The post Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths appeared first on Investor's Business Daily.